# Developing Viability Index for Machine Perfused Livers

> **NCT03694691** · NA · RECRUITING · sponsor: **Massachusetts General Hospital** · enrollment: 60 (estimated)

## Conditions studied

- Liver Cirrhoses

## Interventions

- **DIAGNOSTIC_TEST:** Liver Biopsy

## Key facts

- **NCT ID:** NCT03694691
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2018-10-01
- **Primary completion:** 2028-12-01
- **Final completion:** 2030-06-01
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-11-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03694691

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03694691, "Developing Viability Index for Machine Perfused Livers". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03694691. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*